|
PCNX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.95069999837139E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66339999996268E-07 |
| Normal-vs-Stage2 |
2.46259999999721E-05 |
| Normal-vs-Stage3 |
1.461950E-03 |
| Normal-vs-Stage4 |
2.53569999997261E-06 |
| Stage1-vs-Stage2 |
6.328800E-01 |
| Stage1-vs-Stage3 |
9.157800E-01 |
| Stage1-vs-Stage4 |
2.552800E-01 |
| Stage2-vs-Stage3 |
6.139400E-01 |
| Stage2-vs-Stage4 |
3.795800E-01 |
| Stage3-vs-Stage4 |
2.552600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9697999997792E-07 |
| Normal-vs-AfricanAmerican |
5.0229000003732E-07 |
| Normal-vs-Asian |
9.560600E-04 |
| Caucasian-vs-AfricanAmerican |
5.597000E-01 |
| Caucasian-vs-Asian |
5.901000E-01 |
| AfricanAmerican-vs-Asian |
6.564800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03019997982545E-09 |
| Normal-vs-Female |
1.833780E-02 |
| Male-vs-Female |
5.356500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.568300E-04 |
| Normal-vs-Extreme_Weight |
2.88079999855029E-08 |
| Normal-vs-Obese |
2.170700E-04 |
| Normal-vs-Extreme_Obese |
2.206300E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.778200E-01 |
| Normal_Weight-vs-Obese |
6.798800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.166200E-01 |
| Extreme_Weight-vs-Obese |
1.294560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.731200E-01 |
| Obese-vs-Extreme_Obese |
4.164400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.145200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.592700E-04 |
| Normal-vs-Age(61-80Yrs) |
5.27070054268108E-10 |
| Normal-vs-Age(81-100Yrs) |
1.40969999995466E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.168400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.101700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.063700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.975500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.213900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.397000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.96189999976693E-07 |
| Normal-VS-Type2 PRCC |
8.75689998292017E-09 |
| Normal-VS-KIRP CIMP |
7.068200E-01 |
| Normal-VS-Unclassified PRCC |
8.321700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.728300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.148160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.854400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.297620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.225570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.253400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07539996299744E-09 |
| Normal-vs-N1 |
2.351900E-02 |
| Normal-vs-N2 |
4.001700E-04 |
| N0-vs-N1 |
1.341780E-01 |
| N0-vs-N2 |
4.951800E-01 |
| N1-vs-N2 |
2.878400E-01 |
|
|
